Skip to main content
Figure 2 | Breast Cancer Research

Figure 2

From: The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients

Figure 2

Kaplan-Meier plot of metastasis-free survival ( A ) and breast cancer specific survival ( B ) in patients who did not receive systemic adjuvant treatment ( n = 367). The CTC-positive patients had a poorer MFS and BCSS than CTC-negative patients (MFS HR = 3.0, 95% CI = 1.2 to 7.1, P = 0.014; BCSS HR = 3.6, 95% CI = 1.3 to 9.6, P = 0.011).

Back to article page